Panel Opposes Avodart, Proscar to Prevent Prostate Cancer - WSJ.com
Links shared publicly online about this topic.
- 682total visits
Panel Opposes Avodart, Proscar to Prevent Prostate Cancer - WSJ.com
View full resource at online.wsj.com
Tags: Cancer, Prostate Cancer, Prostate, Drug, Men's Health, Enlarged Prostate
Most Recently Shared on December 3, 2010 at 5:40 pm By:
A panel said drugs used to treat enlarged prostates in men shouldn't be used to prevent prostate cancer. http://ow.ly/1rMHFj
FDA Panel Rejects Use of BPH Drugs for Prostate Cancer Prevention - Renal and Urology News
renalandurologynews.com — “An FDA advisory panel has voted against expanding the labeling of dutasteride (Avodart, GlaxoSmithKline) and finasteride (Proscar, Merck) so that these drugs--"which are indicated for the treatment of benign prostatic hyperplasia (BPH)--"could be marketed for the prevention of prostate cancer (PCa) in men at risk for the disease.” View full resource at renalandurologynews.com
Most Recently Shared on December 3, 2010 at 1:31 pm By:
Renal Urology News Urology, Medical Publisher, Health News, and Nephrology
FDA Panel Rejects Use of BPH Drugs for Prostate Cancer Prevention: An FDA advisory panel has voted against expan... http://bit.ly/dNQ4zo
Medical News: FDA Panel Rejects Prostate Drugs for CA Prevention - in Oncology/Hematology, Prostate Cancer from MedPage Today
medpagetoday.com — “SILVER SPRING, Md. -- An FDA advisory panel has voted overwhelmingly that GlaxoSmithKline's dutasteride (Avodart) and Merck's finasteride (Proscar) should not be used to prevent prostate cancer becaus” View full resource at medpagetoday.com
Most Recently Shared on December 2, 2010 at 12:37 am By:
FDA Panel Rejects Prostate Drugs for CA Prevention http://bit.ly/fgyEA8
FDA panel fails to back Merck & Co.'s Proscar, GlaxoSmithKline's Avodart - FirstWord
firstwordplus.com — “FDA panel fails to back Merck & Co.'s Proscar, GlaxoSmithKline's Avodart - FirstWord” View full resource at firstwordplus.com
Most Recently Shared on December 1, 2010 at 10:42 pm By:
Jack Friday - PharmaGossip Health Blog
RT @fwpharma: FDA panel fails to back Merck's Proscar for prevention of prostate cancer http://bit.ly/hkDIP0
Advertisement
